NCT07205575View on ClinicalTrials.gov

AI-Guided Proteomic Biomarker Panel for Differentiating Bacterial and Viral Infections in Acute Febrile Illness

CompletedOBSERVATIONAL

Enrollment

394

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

October 31, 2024

Study Completion Date

November 30, 2024

Conditions

Acute Febrile IllnessBacterial InfectionsViral InfectionsSepsis

Interventions

DIAGNOSTIC_TEST

Proteomic Biomarker Panel

A blood-based ELISA test measuring circulating ICAM1, CFHR5, and GRN. Index test performance will be evaluated against microbiological gold standards and adjudication.

Trial Locations (1)

250012

Qilu Hospital of Shandong University, Jinan

All Listed Sponsors

lead

Qilu Hospital of Shandong University

OTHER

NCT07205575 - AI-Guided Proteomic Biomarker Panel for Differentiating Bacterial and Viral Infections in Acute Febrile Illness | Biotech Hunter | Biotech Hunter